Key result
Electrocardiographic markers including long-QT interval and microvolt T wave alternans may identify patients at risk for malignant ventricular arrhythmias and those unlikely to benefit from ICDs.
Why the study?
Do electrocardiographic indices like long-QT interval and microvolt T wave alternans help identify patients at risk for life-threatening ventricular arrhythmias?
Do electrocardiographic indices like long-QT interval and microvolt T wave alternans help identify patients at risk for life-threatening ventricular arrhythmias?
Emerging ECG markers like microvolt T wave alternans and QT variability hold promise for noninvasive risk stratification of sudden cardiac death and guiding ICD therapy.
The electrocardiogram (ECG) is indispensable for the diagnosis and management of patients with a wide variety of cardiac and noncardiac diseases. The purpose of this paper is focused on recent research that used ECG, specifically the long-QT interval and microvolt T wave alternans, for the evaluation of life-threatening ventricular arrhythmias. Although remaining to be validated, QT prolongation along with other emerging electrocardiographic indices such as T wave morphology, T peak-to-T end time, or beat-to-beat QT variability may be sensitive indicators of malignant polymorphic ventricular tachyarrhythmia, torsade de pointes. Microvolt T wave alternans may provide important information in identifying a low-risk group with left ventricular dysfunction who is unlikely to benefit from unnecessary prophylactic implantable cardioverter defibrillator therapy. These ECG markers have the potential to aid in the safe administration of individualized medications, avoidance of sudden cardiac death, and provision of a noninvasive strategy to identify patients who are most and least likely to benefit from expensive prophylactic implantable cardioverter defibrillator placement.
No takes yet. Share an insight, caveat, or question.
Wung et al. (2008) conducted a review in Life-threatening ventricular arrhythmias. Electrocardiographic evaluation (long-QT interval and microvolt T wave alternans) was evaluated. Electrocardiographic markers including long-QT interval and microvolt T wave alternans may identify patients at risk for malignant ventricular arrhythmias and those unlikely to benefit from ICDs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: